Skip to main content
Clinical Trials/NL-OMON29741
NL-OMON29741Not yet recruitingNot Applicable

The role of the Anal Fistula Plug combined with infliximab in the treatment of perianal fistula due to Crohn*s disease. -a randomised controlled trial- - inflixiPLUG

Academisch Medisch Centrum0 sites30 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Crohn*s disease
  • Infliximab treatment and chronic loose seton drainage > 2 months
  • High anorectal fistula (transsfincteric, upper 2/3 of the sfinctercomplex which is confined by the puborectal sling and the end of the anal canal)
  • Informed consent

Exclusion Criteria

  • Cryptoglandular fistula
  • Age<18 years
  • HIV-positive
  • No internal opening found during surgery
  • Perianal abscesses on preoperative MRI

Investigators

Similar Trials